Clinical trials
Completed Vascular Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 14 |
| 2014 | 11 |
| 2015 | 6 |
| 2016 | 9 |
| 2017 | 5 |
| 2018 | 11 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 125 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medtronic Vascular | 6 |
| W.L.Gore & Associates | 5 |
| Unilever R&D | 4 |
| University of Edinburgh | 4 |
| Abbott Medical Devices | 3 |
| Cook Research Incorporated | 3 |
| 480 Biomedical | 2 |
| Biotronik AG | 2 |
| Brigham and Women's Hospital | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 125 |
| Cardiovascular Diseases | 47 |
| Brain Diseases | 18 |
| Cerebrovascular Disorders | 18 |
| Stroke | 18 |
| Central Nervous System Diseases | 15 |
| Nervous System Diseases | 14 |
| Hypertension | 13 |
| Peripheral Arterial Disease | 13 |
| Heart Diseases | 11 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.